Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness.

Trovisco V, Soares P, Preto A, de Castro IV, Lima J, Castro P, Máximo V, Botelho T, Moreira S, Meireles AM, Magalhães J, Abrosimov A, Cameselle-Teijeiro J, Sobrinho-Simões M.

Virchows Arch. 2005 Jun;446(6):589-95. Epub 2005 May 19.

PMID:
15902486
2.

BRAF mutation in papillary thyroid carcinoma: pathogenic role and clinical implications.

Tang KT, Lee CH.

J Chin Med Assoc. 2010 Mar;73(3):113-28. doi: 10.1016/S1726-4901(10)70025-3. Review.

3.

Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.

Quiros RM, Ding HG, Gattuso P, Prinz RA, Xu X.

Cancer. 2005 Jun 1;103(11):2261-8. Review.

4.

Clinical impact of the detection of BRAF mutations in thyroid pathology: potential usefulness as diagnostic, prognostic and theragnostic applications.

Lassalle S, Hofman V, Ilie M, Butori C, Bozec A, Santini J, Vielh P, Hofman P.

Curr Med Chem. 2010;17(17):1839-50. Review.

PMID:
20345340
5.

BRAF mutations in papillary thyroid carcinoma.

Wojciechowska K, Lewinski A.

Endocr Regul. 2006 Dec;40(4):129-38. Review.

PMID:
17201587
6.

Alterations of the BRAF gene in thyroid tumors.

Ciampi R, Nikiforov YE.

Endocr Pathol. 2005 Fall;16(3):163-72. Review.

PMID:
16299399
7.

[BRAF gene mutation in thyroid cancer].

Kopczyńska E, Junik R, Tyrakowski T.

Pol Merkur Lekarski. 2006 Feb;20(116):210-3. Review. Polish.

PMID:
16708643
8.

Synchronous occurrence of medullary and papillary carcinoma of the thyroid in a patient with cutaneous melanoma: determination of BRAFV600E in peripheral blood and tissues. Report of a case and review of the literature.

Fibbi B, Pinzani P, Salvianti F, Rossi M, Petrone L, De Feo ML, Panconesi R, Vezzosi V, Bianchi S, Simontacchi G, Mangoni M, Pertici M, Forti G, Pupilli C.

Endocr Pathol. 2014 Sep;25(3):324-31. doi: 10.1007/s12022-014-9303-1. Review.

PMID:
24858900
9.

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications.

Xing M.

Endocr Rev. 2007 Dec;28(7):742-62. Epub 2007 Oct 16. Review.

PMID:
17940185
10.

[BRAF initiating mutations in the papillary thyroid carcinoma].

Rusinek D, Gubała E.

Endokrynol Pol. 2006 Jul-Aug;57(4):438-44. Review. Polish.

PMID:
17006850
11.

Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions.

Handkiewicz-Junak D, Czarniecka A, Jarzab B.

Mol Cell Endocrinol. 2010 Jun 30;322(1-2):8-28. doi: 10.1016/j.mce.2010.01.007. Epub 2010 Feb 4. Review.

PMID:
20138116
12.

BRAF mutations in papillary thyroid carcinoma and emerging targeted therapies (review).

Leonardi GC, Candido S, Carbone M, Raiti F, Colaianni V, Garozzo S, Cinà D, McCubrey JA, Libra M.

Mol Med Rep. 2012 Oct;6(4):687-94. doi: 10.3892/mmr.2012.1016. Epub 2012 Aug 2. Review.

PMID:
22858857
13.
14.

Role of BRAF in thyroid oncogenesis.

Caronia LM, Phay JE, Shah MH.

Clin Cancer Res. 2011 Dec 15;17(24):7511-7. doi: 10.1158/1078-0432.CCR-11-1155. Epub 2011 Sep 7. Review.

15.

Targeting of the BRAF gene in papillary thyroid carcinoma (review).

Li Y, Nakamura M, Kakudo K.

Oncol Rep. 2009 Oct;22(4):671-81. Review.

PMID:
19724843
16.

How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer.

Couto JP, Prazeres H, Castro P, Lima J, Máximo V, Soares P, Sobrinho-Simões M.

J Clin Pathol. 2009 May;62(5):414-21. doi: 10.1136/jcp.2008.055343. Epub 2009 Jan 15. Review.

PMID:
19147628
17.

[BRAF gene mutation in the natural history of papillary thyroid carcinoma: diagnostic and prognostic implications].

Lopes JP, Fonseca E.

Acta Med Port. 2011 Dec;24 Suppl 4:855-68. Epub 2011 Dec 31. Review. Portuguese.

18.

The association between BRAF (V600E) mutation and pathological features in PTC.

Liu X, Yan K, Lin X, Zhao L, An W, Wang C, Liu X.

Eur Arch Otorhinolaryngol. 2014 Nov;271(11):3041-52. doi: 10.1007/s00405-013-2872-7. Epub 2014 Jan 4. Review.

PMID:
24389984
19.

RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis.

Ciampi R, Nikiforov YE.

Endocrinology. 2007 Mar;148(3):936-41. Epub 2006 Aug 31. Review.

PMID:
16946010
20.

Roles of RAS and BRAF mutations in thyroid carcinogenesis.

Fukushima T, Takenoshita S.

Fukushima J Med Sci. 2005 Dec;51(2):67-75. Review.

Supplemental Content

Support Center